Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v4-FR
Language French French
Date Updated 2019-11-21 2019-04-30
Drug Identification Number 02326663 02326663
Brand name ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP
Common or Proper name Onguent Ophtalmique d'Érythromycine USP Onguent Ophtalmique d'Érythromycine USP
Company Name LABORATOIRES STERIGEN INC LABORATOIRES STERIGEN INC
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 5MG 5MG
Dosage form(s) OINTMENT OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3.5g 3.5g
ATC code S01AA S01AA
ATC description ANTIINFECTIVES ANTIINFECTIVES
Reason for shortage Other (Please describe in comments) Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-12-31 2018-12-31
Estimated end date 2019-12-20 2019-08-16
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Pending of analysis
Health Canada comments